Anatomic Pathology Market - Scope, Size, Share, Analysis, Statistics & Trends

Posted by Rama Sharma on July 8th, 2019

According to the new market research report " Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021", published by MarketsandMarkets™, The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021.

 Don’t miss out on business opportunities in Anatomic Pathology Market, visit: https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

 Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

The reagents, and consumables segment to dominate the overall Anatomic Pathology Market

The global anatomic pathology market is segmented based on product & service, application, and region. On the basis of product & service, the market is segmented into instruments, consumables, and services. In 2016, the services segment accounted for the largest share of the Anatomical pathology market. This growth can be attributed to increasing ageing population; increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests. For instance, According to the WHO, the population aged 60 years and over across the globe is expected to double from about 11% in 2000 to 22% in 2050. The number of people over 60 years of age will increase from 605 million to 2 Billion over the same period. Similarly, according to GLOBOCAN, globally, the incidence of cancer was 15.2 Million in 2015 and is expected to reach 19 Million by 2025

Browse and in-depth TOC on "Anatomic Pathology Market"

80  - Tables

32  - Figures

129 - Pages

Get Sample Copy for more Professional and Technical insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

On the basis of application, the market is segmented into disease diagnosis, drug discovery & development, and other applications. In 2016, the disease diagnosis segment accounted for the largest share of the market. The growth in this segment primarily attributed to increasing prevalence of chronic diseases

Make an Inquiry Prior To Purchase this research study @ https://www.marketsandmarkets.com/ResearchInsight/anatomic-pathology-market.asp

The report "Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021", This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, trends and strategies impacting the anatomic pathology market, along with revenue estimates & forecasts and market share analysis.

To know about the assumptions considered for the study, download the pdf brochure

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.